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Abstract Covalent binding of the antitumour antibiotic bedamy- 
tin to the self-complementary hexadeoxyribonucleotide 5'- 
CACGTG-3' has been investigated by electrospray ionization 
mass spectrometry (ESI-MS). Ions due to double-stranded forms 
of the free 5'-CACGTG-3' and the hedamycin-5'- CACGTG-3' 
adduct have been observed in ESI mass spectra and their identity 
has been confirmed by resolution of individual charge states in 
ESI-MS spectra. Clear evidence that specific base-paired associ- 
ations are being observed in ESI-MS is provided by the results 
of a titration experiment involving alkylated and non-alkylated 
complementary strands. This work demonstrates the potential of 
this powerful new tool for studying ligand-DNA binding. 
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1. Introduction 
Electrospray ionization mass spectrometry (ESI-MS) is now 
extensively applied for the characterization f biomolecules, in
particular proteins [1,2]. This is a very gentle ionization tech- 
nique with multiply-charged ions from the species of interest 
and minimal fragmentation generally observed in ESI mass 
spectra. As a consequence, there is considerable interest in the 
applications of ESI-MS for the detection of non-covalent asso- 
ciations of biomolecules, and recently ions corresponding to 
double-stranded or duplex forms of oligonucleotides have been 
reported in ESI mass spectra [3,4]. Gale et al. [5] have also done 
a preliminary study of a non-covalent complex between dis- 
tamycin and an oligonucleotide uplex. ESI-MS has considera- 
ble promise for the structural characterization f l igand binding 
to DNA, offering potential advantages of sensitivity and speed 
of analysis, compared with existing structural methods uch as 
NMR and X-ray crystallography. 
Hedamycin (Fig. 1) is a naturally occurring antitumour anti- 
biotic that can both intercalate into and alkylate double- 
stranded DNA [6]. We have conducted extensive sequence anal- 
yses of hedamycin binding to purified plasmid and human 
DNAs [7], and also to DNA in intact human tumour cells [8]. 
These studies have demonstrated high levels of binding to iso- 
lated guanines, particularly those located in 5'-CGT sequences, 
and suggest hat the N7 of guanine is the nucleophilic site on 
DNA. We have an on-going program aimed at elucidating the 
structural basis for this sequence selectivity, as well as for those 
of other naturally occurring and synthetic DNA intercalating/ 
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alkylating compounds. To date, these structural studies have 
involved the use of NMR spectroscopy, but this work is now 
complemented by our development of new mass spectral meth- 
ods for assessing ligand binding to DNA. 
In this paper, we demonstrate he use of ESI mass spectrom- 
etry to examine the covalent binding of hedamycin to the self- 
complementary hexadeoxyribonucleotide 5'-CACGTG-3',  
which incorporates a single preferred binding site. Further- 
more, we provide here the first clear evidence for the formation 
of specifically base-paired DNA duplex ions from a covalent 
l igand-DNA adduct in ESI mass spectra, thus opening the way 
for ESI-MS to be used as a sensitive structural probe for ligand 
binding to double-helical DNA. 
2. Materials and methods 
2.1. Preparation and purification of hedamycin-CACGTG adduct 
The self-complementary deoxyribonucleotide 5'-CACGTG-Y was 
synthesized 'trityl-on' with an Applied Biosystems Model 381A DNA 
synthesizer, using ,&cyanoethylphosphoramidite chemistry. The crude 
trityl-on oligonucleotide was purified on a Waters Delta-Pak C18 re- 
verse-phase HPLC cartridge system with a linear gradient of acetoni- 
trile in 0.1 M aqueous ammonium acetate (pH 7.0). The purified ol- 
igonucleotide was detritylated with 80% acetic acid and re-chromato- 
graphed using the same stationary phase and solvent system. 
A sample of hedamycin was generously donated by the Bristol-Myers 
Co. (USA) and was used without further purification. A stock solution 
of hedamycin was prepared by dissolving the solid in a minimum vol- 
ume of acetonitrile and then diluting to the appropriate volume with 
0.1 M aqueous ammonium acetate (pH 7.0). The stock solution (1.4 
mM) was kept under nitrogen and was stored at -20°C in the dark. 
Reactions between hedamycin and 5'-CACGTG-3' were carried OUt 
at room temperature under a nitrogen atmosphere and in the dark. 
Ligand stock solution was added to the oligonucleotide issolved in 0.1 
M ammonium acetate (pH 7.0) in a mole ratio of 1:1 hedamycird 
(oligonucleotide uplex). Reactions were monitored by reverse-phase 
HPLC, using the system described above. When reactions were judged 
to be complete, the major components in the mixtures were isolated by 
preparative HPLC, the solvent evaporated and each examined by ESI- 
MS as described below. 
2.2. Electrospray mass spectrometry 
The majority of ESI-MS spectra were acquired on a VG Biotech 
Quattro mass spectrometer quipped with an electrospray ionization 
source and a triple quadrupole mass analyser, which has a mass range 
for singly charged ions of 4000 Da. The resolution of the quadrupole 
was set to 1.5 Da (peak width at half-height). Under these conditions 
the isotopic species from multiply charged ions were not fully resolved, 
although quadrupole mass analysers can be used to resolve isotopes of 
triply charged ions in favourable cases. Oligonucleotide samples were 
dissolved in 50-100/.tl of 10 mM aqueous ammonium acetate. The 
concentration f single-stranded oligonucleotide in these samples was 
50-200 pmol/pl. An injection volume of 10/~1 was used for each analy- 
sis. Samples were introduced into the source by a flow of solvent at 
5/ll/min. A flow of warm, dry nitrogen (65°C, 1 atm) assisted evapora- 
tion of the solvent. The electrospray probe tip potential was 3.5 kV, 
with 0.5 kV on the chicane counter electrode. Spectra were acquired 
in negative ion mode over a range rrdz 300-1700 scanned at a rate of 
0014-5793/95l$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
SSDI  0014-5793(95)001 10-7 
232 
100 mass units per second. The mass range in this mode was calibrated 
using a standard sugar mixture. A skimmer potential of 50 V was used 
for all oligonucleotide and oligonucleotide-adduct analyses. 
Additional mass spectra were acquired on a Fisons Analytical MS 
Autospec magnetic sector mass spectrometer. Samples were approxi- 
mately 150 pmol/ltl in 10 mM aqueous ammonium acetate. A 20/11 
aliquot was used for injection and the solvent flow was 40 Itl/min. A 
resolution of 3000 was used for each analysis, which was sufficient to 
easily resolve individual isotopic species from triply charged oligonucle- 
otides. 
3. Results and discussion 
Fig. 2 shows the ESI mass spectrum of d(CACGTG) follow- 
ing HPLC purification. There are two major peaks in the spec- 
trum from the single-stranded oligonucleotide, namely the [M- 
2H] 2- ion at m/z 895 and the [M-3H] 3- at m/z 596. There is also 
a significant peak at m/z 1194 which we have attributed to the 
double-stranded oligonucleotide l ss three protons [2M-3H] 3- 
(the charge of this peak has been confirmed by high resolution 
ESI-MS; see below). The intensity of this peak depends on the 
solvent composition. A wide range of solvents were tested and 
the optimum was found to be 10 mM ammonium acetate. This 
is consistent with earlier eports of duplex formation that noted 
that the presence of an appropriate buffer was necessary for 
these ions to be observed in ESI mass spectra [2,3]. This was 
also the evidence provided by these workers for the formation 
of duplex DNA stabilised by the presence of counter ions as 
opposed to non-specific gas-phase associations of these mole- 
cules. 
Fig. 3a shows the ESI-MS of the hedamycin-d(CACGTG) 
adduct following HPLC purification. The two major peaks in 
the spectrum are both due to the single-stranded a duct, i.e. 
[M-3H] 3- at m/z 845 and [M-2H] 2- at m/z 1268. There are no 
duplex ions evident in this spectrum. That the mass spectrum 
of the purified hedamycin-DNA adduct shows no association 
between alkylated strands is understandable given that the 
hedamycin binding site is located in the centre of the sequence. 
In order for two adducts to form a fully basepaired duplex, the 
bulky hedamycin ligands would have to be placed in close 
proximity to each other, being attached to guanines that are on 
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Fig. 1. Structure of hedamycin (Mr = 746.85). 
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Fig. 2. Electrospray mass spectrum (ESI-MS) of d(CACGTG) 
(Mr = 1792.2). 
opposite strands and in neighbouring basepairs, and this would 
lead to severe steric interactions. 
Therefore, to generate a stable duplex from the purified ad- 
duct, we conducted a titration experiment where aliquots of 
free 5'-CACGTG-3' were added to the purified, single-stranded 
hedamycin-5'-CACGTG-Y adduct, with mass spectra being 
collected after each addition. After the first addition, a low 
intensity peak corresponding to hedamycin~t(CACGTG)2 at 
rn/z 1443 (due to the [M-3H] 3- ion) appeared in the mass spec- 
trum (not shown). With each subsequent addition, the intensity 
of this peak increased up until one equivalent was added, in 
which case the duplex ion was the major peak in the spectrum 
(Fig. 3b) and there was only a small peak due to the single- 
stranded adduct. A new peak (at lrdz 895), due to free single- 
stranded 5'-CACGTG-Y, was also apparent. These results 
clearly indicate that the hedamycin-d(CACGTG)2 adduct peak 
seen in the ESI mass spectra is due to specific basepairing 
between the hedamycin-5'-CACGTG-3' adduct and the com- 
plementary 5'-CACGTG-3' strand. This interpretation is con- 
sistent with both NMR spectroscopic evidence (Wickham et al., 
unpublished results) that hedamycin remains intercalated after 
alkylation of the guanine and earlier studies which show that 
hedamycin increases duplex stability [6]. In the ESI-MS spec- 
trum of the free 5'-CACGTG-Y (Fig. 2), even under the most 
favourable ionization conditions, the duplex form is only ob- 
served in ~25% abundance relative to the single-stranded ol-
igonucleotide. In contrast, the hedamycin-d(CACGTG)2 du- 
plex is the most abundant species observed in Fig. 3b, which 
reflects the additional duplex stability arising from hedamycin 
intercalating between the two strands. 
Finally, it should be noted that in ESI spectra containing 
multiply charged ions, the masses are derived using simple 
algorithms based on the mass difference between two multiply 
charged peaks with different charge states [9]. However, when 
there is only one peak, as is the case for many of the duplex 
peaks from small oligonucleotides and ligand-oligonucleotide 
adducts, the charge state of the peak, and hence the mass, can 
be determined from the spacing of individual isotopic species 
containing one and more 13C-labeled isotopes, which differ in 
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Fig. 3. ESI-MS of hedamycin~l(CACGTG) (Mr = 2539.1) (a) following HPLC purification, showing only single-stranded hedamycin~l(CACGTG) 
and (b) after titration with approximately one equivalent of free d(CACGTG), showing the formation of hedamycin-d(CACGTG)2 (Mr = 4331.3) 
mass by 1.003 Da. Fig. 4 shows two of the major ions from the 
spectra in Fig. 3 measured with a resolution of 3000. In the 
examples here, the m/z separation of 0.5 between adjacent 
peaks in Fig. 4a confirms that this ion of the single-stranded 
hedamycin-d(CACGTG) adduct has two charges, whereas in 
Fig. 4b the spacing of ~ 0.3 indicates that the observed hedamy- 
cin~I(CACGTG)2 double-stranded a duct is a triply charged 
species. 
In conclusion, therefore, while we and others have observed 
ions corresponding to duplex forms of DNA in ESI-mass spec- 
tra, the results described here are the first example of a covalent 
ligand-(duplex DNA) adduct. That no peaks corresponding to
duplex DNA were observed for the sterically hindered al- 
kylated oligonucleotide alone, but were readily observed when 
free oligonucleotide was added to the alkylated strand, provides 
strong evidence that stable, specifically basepaired duplexes are 
being observed in the mass spectrometer. Furthermore, the 
relative intensities of the ions observed in the ESI mass spectra 
reflect the greater stability of the hedamycin~l(CACGTG)2 
adduct compared to the free d(CACGTG)2, consistent with 
other evidence that hedamycin both alkylates and intercalates 
into DNA. Thus, we anticipate that ES1-MS will prove to be 
an extremely valuable tool for the structural analysis of ligand 
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Fig. 4. ESI-MS obtained with a resolution of 3000 which is sufficient 
to resolve individual isotopic species of (a) [hedamycin~d(CACGTG)- 
2H] 2-. The peaks are separated by 0.5 confirming these are 2- ions; and 
(b) [hedamycin-d(CACGTG)z-3H] 3-, inwhich the spacing of~0.3 indi- 
cates these are 3- ions. 
